Skip to main content
Erschienen in: Reproductive Health 3/2020

Open Access 01.12.2020 | Research

Rates and risk factors for preterm birth and low birthweight in the global network sites in six low- and low middle-income countries

verfasst von: Yamini V. Pusdekar, Archana B. Patel, Kunal G. Kurhe, Savita R. Bhargav, Vanessa Thorsten, Ana Garces, Robert L. Goldenberg, Shivaprasad S. Goudar, Sarah Saleem, Fabian Esamai, Elwyn Chomba, Melissa Bauserman, Carl L. Bose, Edward A. Liechty, Nancy F. Krebs, Richard J. Derman, Waldemar A. Carlo, Marion Koso-Thomas, Tracy L. Nolen, Elizabeth M. McClure, Patricia L. Hibberd

Erschienen in: Reproductive Health | Sonderheft 3/2020

Abstract

Background

Preterm birth continues to be a major public health problem contributing to 75% of the neonatal mortality worldwide. Low birth weight (LBW) is an important but imperfect surrogate for prematurity when accurate assessment of gestational age is not possible. While there is overlap between preterm birth and LBW newborns, those that are both premature and LBW are at the highest risk of adverse neonatal outcomes. Understanding the epidemiology of preterm birth and LBW is important for prevention and improved care for at risk newborns, but in many countries, data are sparse and incomplete.

Methods

We conducted data analyses using the Global Network’s (GN) population-based registry of pregnant women and their babies in rural communities in six low- and middle-income countries (Democratic Republic of Congo, Kenya, Zambia, Guatemala, India and Pakistan). We analyzed data from January 2014 to December 2018. Trained study staff enrolled all pregnant women in the study catchment area as early as possible during pregnancy and conducted follow-up visits shortly after delivery and at 42 days after delivery. We analyzed the rates of preterm birth, LBW and the combination of preterm birth and LBW and studied risk factors associated with these outcomes across the GN sites.

Results

A total of 272,192 live births were included in the analysis. The overall preterm birth rate was 12.6% (ranging from 8.6% in Belagavi, India to 21.8% in the Pakistani site). The overall LBW rate was 13.6% (ranging from 2.7% in the Kenyan site to 21.4% in the Pakistani site). The overall rate of both preterm birth and LBW was 5.5% (ranging from 1.2% in the Kenyan site to 11.0% in the Pakistani site). Risk factors associated with preterm birth, LBW and the combination were similar across sites and included nulliparity [RR − 1.27 (95% CI 1.21–1.33)], maternal age under 20 [RR 1.41 (95% CI 1.32–1.49)] years, severe antenatal hemorrhage [RR 5.18 95% CI 4.44–6.04)], hypertensive disorders [RR 2.74 (95% CI − 1.21–1.33], and 1–3 antenatal visits versus four or more [RR 1.68 (95% CI 1.55–1.83)].

Conclusions

Preterm birth, LBW and their combination continue to be common public health problems at some of the GN sites, particularly among young, nulliparous women who have received limited antenatal care services.
Trial registration The identifier of the Maternal and Newborn Health Registry at ClinicalTrials.gov is NCT01073475.Trial registration: The identifier of the Maternal and Newborn Health Registry at ClinicalTrials.gov is NCT01073475.
Hinweise
Yamini V. Pusdekar and Archana B. Patel contributed equally to this work

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ANC
Antenatal care
BMI
Body mass index
DRC
Democratic Republic of Congo
g/dL
Grams per deciliter
GEE
Generalized estimating equations
GLM
Generalized linear models
GN
Global network
LBW
Low birth weight
LMICs
Lower and middle income countries
LMP
Last menstrual period
MNHR
Maternal and Newborn Health Registry
NICHD’s
National Institute for Child Health and Human Development`s
RR
Risk ratios
RTI
Research Triangle Institute
SGA
Small for gestational age

Background

Addressing the global burden of preterm birth (before 37 weeks of pregnancy) is critical to reducing neonatal and childhood mortality and to achieving Sustainable Development Goal #3—to ensure healthy lives and to promote well-being for all at all ages [1]. The World Health Organization (WHO) estimates that there are 15 million preterm births every year [2]. Gestational age is more predictive of risk of neonatal and childhood mortality than low birth weight (LBW—below 2500 g), but prematurity is more difficult to ascertain accurately than birthweight. Ninety-seven percent of LBW babies are born in low and lower-middle income countries (LMIC) where estimates of gestational age are the most difficult to ascertain. Therefore, the WHO also estimates the number of babies born with LBW, currently 25 million babies annually [2]. Although prematurity is a major reason for a baby being born LBW, LBW is an imperfect surrogate for preterm birth. Term babies may also be LBW because they are growth restricted and small for gestational age (SGA) that weigh less than 10th percentile of weight for gestational age and sex, resulting in an estimated 67% overlap between preterm birth and LBW [3, 4]. Mechanisms and risk factors for preterm and for LBW babies may differ despite a substantial proportion of LBW being contributed by preterm births as LBW infants are also a result of intrauterine growth restriction [5]. LBW and/or preterm birth are important causes of neonatal mortality. In 2015, there were an estimated 1 million deaths in children under age 5 years globally attributed to prematurity [6]. Infants who are SGA have an increased risk of neonatal mortality regardless of their association with preterm birth [7]. Thirty five percent of neonatal deaths were attributed to prematurity [8] and more than 80% of neonatal deaths were in LBW babies [9].
There have been calls for improved estimates of the burden of preterm birth and LBW, particularly in countries where the data are sparse, incomplete or not population-based [8]. There is limited information on maternal factors associated with these neonatal conditions and whether and how they may occur in rural settings in LMICs. More accurate data may enable government policies and programs to more effectively target interventions to reduce preterm birth and LBW. Neonatal mortality in LBW preterm babies is higher, with more severe lifelong consequences, than for LBW and preterm babies alone and therefore accurate estimates of and risk factors for the combination are needed to improve survival of these newborns [10].
The Eunice Kennedy Shriver National Institute of Child Health and Human Development’s (NICHD’s) Global Network (GN), is a multi-site research network representing partnerships of U.S. and international investigators at rural and semi-urban study sites in Guatemala, India (2 sites:Nagpur and Belgaum), Pakistan, Kenya, Zambia and the Democratic Republic of the Congo. The GN Maternal and Newborn Health Registry (MNHR) has been collecting data on a population-based sample of pregnant women and their babies starting in 2008. The GN has consistently focused on improving the quality of its data [11], by focusing on obtaining accurate and standardized methods of assessing birth weight and gestational age data across all participating sites. Gestational age data has been improved over time by increased access to ultrasound dating, mostly from January 2014. Standardized training of sonographers has also been possible across the GN as ultrasounds were required for three GN studies [1214] that drew their study participants from subjects participating in the MNHR. Here we describe and compare the rates of preterm births, LBW and a combination of preterm birth and LBW at the GN sites. We also explored and compared the maternal, delivery and infant characteristics as risk factors associated with preterm birth, LBW and both preterm birth and LBW for the GN sites.

Methods

Study design, setting and participants

This study is a secondary data analysis using the GN’s population-based MNHR. The details of the MNHR have been published [15]. The MNHR started in 2008 and has registered approximately 70,000 pregnant women and their babies annually in rural and semi-urban communities in the countries listed above. Each site has included 6–24 distinct geographic locations (clusters). The registry continues to prospectively identify, consent, screen and enroll pregnant women in the study communities as early as possible in their pregnancy. The enrollment target in all participating communities (clusters) is at least 95% of pregnant women. Pregnant women included in this analysis were screened, consented and enrolled in the MNHR between January 2014 and December 2018, since first trimester ultrasound for gestational age dating and quality assurance efforts to improve the accuracy of reporting of last menstrual period (LMP) were consistently adopted sites.

Eligibility criteria

Women were excluded from the analysis if they did not consent; were lost to follow-up prior to delivery; or if the information on gestational age at birth, vital status or birth weight was missing. Women who died prior to delivery, who had a miscarriage or medical termination of pregnancy, a multiple birth or a stillbirth were also excluded from analysis.

Data collection process, co-variates and quality control

Data on the enrolled women were collected by trained health workers at three time points: at enrolment (as early as possible in pregnancy: age, educational status, height [except in the Kenya site that did not collect maternal height until 2017], weight, maternal BMI collected on enrollment, parity, date of LMP, expected date of delivery, and hemoglobin levels [two sites that had data available for most of the study period]); at delivery (receipt of iron, vitamins or calcium and the tetanus toxoid immunization during this pregnancy; number of antenatal care (ANC)visits; antenatal ultrasound information; date of delivery; gender of the baby; birth weight; mode of delivery; maternal conditions such as obstructed labor, severe antepartum or postpartum hemorrhage, hypertensive disorders, and fetal malpresentation; neonatal status; and place of delivery); at 42 days postpartum (maternal mortality, neonatal survival, and hospitalizations of the mother or baby) [1620].
Senior Foreign Investigators (on-site primary investigators) at all sites were trained centrally. They then trained their site’s data collectors prior to collecting study data. Data sources included medical records as well as interviews with the participating women. Data collected on paper were entered into a database at a site-based data management center and transmitted to a central data coordinating center at Research Triangle Institute (RTI), Durham, NC, USA. RTI monitored the data with monthly reports of data quality (completeness and timeliness) and edit reports to identify out of range or inconsistent data that were then addressed by the site staff as well site visits.

Outcomes

The primary outcomes for the study were rates of preterm birth, rates of LBW and their combination. Preterm birth rate was defined as the number of neonates delivered before 37 completed weeks of gestation per 100 live births. Gestational age was estimated from the most reliable variable using the following hierarchy of reliability (1) ultrasound, (2) date of LMP, if menses are regular, (3) neonatal examination and (4) gestational age recorded at birth. The LMP was considered reliable if the LMP date given was consistent with other information about the pregnancy (i.e., plausible date), the pregnant woman states that she has a regular menstrual cycle, seems relatively sure of the date and was not using contraception. Ultrasound examinations were conducted either as a part of a GN study wherein standardized training was provided to sonologists or as a part of routine antenatal care. However, availability of ultrasound information any time during pregnancy with information on gestational age varied across sites. Additionally, babies with birthweight between the 99th percentile at 36 week (based on country-specific growth data: DRC = 3086, Zambia = 3093, Guatemala = 2959, Belagavi, India = 2784, Pakistan = 2849, Nagpur = 2680, Kenya = 3311) and 5500 g were classified as term births [21, 22].
Low birth weight (LBW) rate was defined as the number of neonates with a birthweight less than 2,500 g per 100 live births. Birth weight was measured (not estimated) within 6 days of birth in more than 96.8% of neonates in the MNHR [15].
Preterm and LBW rate was defined as the number of neonates both preterm birth and LBW per 100 live births.

Ethical clearance

The Institutional Review Boards and Ethics Research Committees of all participating institutions approved the MNHR. Prior to initiation of the study, agreement to participate was obtained from the communities through sensitization meetings. Individual informed consent for study participation was required from each study participant. No monetary reimbursements were provided to study participants nor to the communities participating in the study. A Data Monitoring Committee appointed by NICHD oversaw and reviewed the study at annual meetings.

Statistical analysis

We computed summary statistics (e.g., n and proportions) overall and by GN site for rates of preterm birth, LBW and the combination of preterm and LBW, as well as maternal and neonatal characteristics. Generalized linear models (GLM) with generalized estimating equation (GEE) working correlation structure were used to evaluate the relationship of potential factors and preterm birth, LBW and the combination of preterm birth and LBW to develop point and interval estimates of relative risk associated with these factors. GEE were used to account for the correlation of outcomes within cluster to develop appropriate confidence intervals. The risk ratios for the factors associated with preterm birth, LBW, and their combination in the overall study population and by site are represented graphically and also described using multivariable regression analyses separately for preterm birth, LBW and their combination. All analyses were conducted in SAS 9.4 (RTI Inc., Durham, NC). A two-sided p-value < 0.05 was considered to be statistically significant.

Results

From January 2014 to December 2018, a total of 303,883 women were screened. Among these, 272,192 (89.6%) met the inclusion criteria of maternal survival through delivery and a pregnancy resulting in a singleton, live birth with gestational age and birth weight assessed.
These mother-baby pairs were analyzed for rates of preterm birth, LBW and the combination of both preterm birth and LBW (Fig. 1). For this population, gestational age was based on ultrasound for 18.5% of babies, LMP for 68.1%, clinical exam for 1.6%, as collected at delivery (usually by LMP) for 6.1%, and weight for 5.7%.

Maternal, delivery and infant characteristics of the study population

As shown in Table 1, more than 80% of the women were aged 20–35 years across all GN sites, but 19–24% of the women in the Africa sites vs. 2–12% of the women in the Asian sites were less than age 20 years of age. Overall, almost 79% had completed at least primary and secondary education, but 82% of women in the Pakistani site and 38% of women in the DRC site had no formal education.
Table 1
Maternal, delivery and infant characteristics by Global Network Site
Characteristic
Overall, all sites
DRC
Zambia
Kenya
Guatemala
Belagavi, India
Nagpur, India
Pakistan
Deliveries, N
272,192
29,796
33,918
36,166
52,047
40,172
41,894
38,199
Maternal age
272,094
29,767
33,906
36,110
52,047
40,172
41,894
38,198
 < 20
38,388 (14.1)
5744 (19.3)
194 (24.2)
8166 (22.6)
8915 (17.1)
4684 (11.7)
981 (2.3)
1704 (4.5)
 20–35
219,304 (80.6)
21,493 (72.2)
22,992 (67.8)
26,402 (73.1)
37,865 (72.8)
35,360 (88.0)
40,701 (97.2)
34,491 (90.3)
 > 35
14,402 (5.3)
2530 (8.5)
2720 (8.0)
1,542 (4.3)
5267 (10.1)
128 (0.3)
212 (0.5)
2003 (5.2)
Maternal education
272,095
29,795
33,910
36,119
52,047
40,170
41,858
38,196
 No formal education
58,512 (21.5)
11,278 (37.9)
2509 (7.4)
528 (1.5)
6428 (12.4)
5236 (13.0)
1296 (3.1)
31,237 (81.8)
 Primary/secondary
195,792 (72.0)
18,450 (61.9)
30,903 (91.1)
32,458 (89.9)
42,076 (80.8)
31,346 (78.0)
34,140 (81.6)
6419 (16.8)
 University+ 
17,791 (6.5)
67 (0.2)
498 (1.5)
3133 (8.7)
3543 (6.8)
3588 (8.9)
6422 (15.3)
540 (1.4)
Parity
270,083
29,795
33,915
36,124
52,046
40,170
41,867
36,166
 0
84,753 (31.4)
5,598 (18.8)
10,454 (30.8)
11,737 (32.5)
15,479 (29.7)
14,585 (36.3)
20,804 (49.7)
6,096 (16.9)
 1–2
113,835 (42.1)
9350 (31.4)
13,300 (39.2)
14,136 (39.1)
20,972 (40.3)
22,795 (56.7)
20,239 (48.3)
13,043 (36.1)
 > 2
71,495 (26.5)
14,847 (49.8)
10,161 (30.0)
10,251 (28.4)
15,595 (30.0)
2,790 (6.9)
824 (2.0)
17,027 (47.1)
Antenatal iron/calcium/vitamins
272,136
29,790
33,918
36,166
52,044
40,166
41,854
38,198
 Received any
260,290 (95.6)
28,087 (94.3)
33,847 (99.8)
35,558 (98.3)
50,117 (96.3)
39,474 (98.3)
41,751 (99.8)
31,456 (82.3)
Tetanus toxoid immunization received
272,079
29,789
33,917
36,166
51,967
40,170
41,871
38,199
 Yes
230,906 (84.9)
26,108 (87.6)
30,911 (91.1)
32,884 (90.9)
39,514 (76.0)
40,117 (99.9)
41,791 (99.8)
19,581 (51.3)
 At least one ANC visit
272,155
29,796
33,918
36,164
52,036
40,171
41,872
38,198
 Yes
266,816 (98.0)
28,775 (96.6)
33,889 (99.9)
35,826 (99.1)
49,841 (95.8)
40,159 (100.0)
41,763 (99.7)
36,563 (95.7)
Number of ANC visits
271,910
29,758
33,916
36,138
51,961
40,166
41,798
38,173
 0
5339 (2.0)
1021 (3.4)
29 (0.1)
338 (0.9)
2195 (4.2)
12 (0.0)
109 (0.3)
1635 (4.3)
 1–3
102,119 (37.6)
14,790 (49.7)
17,978 (53.0)
15,044 (41.6)
16,968 (32.7)
10,642 (26.5)
5,415 (13.0)
21,282 (55.8)
 4+
164,452 (60.5)
13,947 (46.9)
15,909 (46.9)
20,756 (57.4)
32,798 (63.1)
29,512 (73.5)
36,274 (86.8)
15,256 (40.0)
Obstructive labor
272,180
29,796
33,918
36,166
52,045
40,171
41,885
38,199
 Yes
14,021 (5.2)
438 (1.5)
869 (2.6)
1148 (3.2)
2271 (4.4)
3433 (8.5)
468 (8.3)
2394 (6.3)
Severe antepartum hemorrhage
272,179
29,796
33,917
36,166
52,043
40,171
41,887
38,199
Yes
1361 (0.5)
60 (0.2)
162 (0.5)
202 (0.6)
124 (0.2)
179 (0.4)
71 (0.2)
563 (1.5)
Severe postpartum hemorrhage
270,473
29,786
33,368
35,377
52,015
40,170
41,558
38,199
 Yes
3041 (1.1)
178 (0.6)
189 (0.6)
438 (1.2)
426 (0.8)
639 (1.6)
66 (0.2)
1105 (2.9)
Hypertensive disorders
272,108
29,744
33,913
36,165
52,032
40,171
41,887
38,196
 Yes
5904 (2.2)
12 (0.0)
284 (0.8)
150 (0.4)
2069 (4.0)
1538 (3.8)
983 (2.3)
868 (2.3)
Fetal malpresentation
272,154
29,774
33,917
36,163
52,044
40,171
41,886
38,199
 Yes
4564 (1.7)
108 (0.4)
196 (0.6)
260 (0.7)
1499 (2.9)
653 (1.6)
755 (1.8)
1093 (2.9)
Sex of the baby
272,177
29,794
33,915
36,166
52,043
40,169
41,892
38,198
 Female
132,674 (48.7)
14,351 (48.2)
16,794 (49.5)
18,026 (49.8)
25,428 (48.9)
19,391 (48.3)
20,141 (48.1)
18,543 (48.5)
Overall, 31% of the women were nulliparous, ranging from 17% in the Pakistani site to 50% in the Nagpur site. During antenatal period, more than 94% of the women received at least any one of iron, vitamins or calcium in all sites, except in the Pakistani site where only 82% had received one or more of these supplements. A similar pattern was seen with administration of tetanus toxoid (76% or more in all sites were immunized except in the Pakistan site, where the rate was 51%).
Overall, 60% of the women had four or more antenatal care (ANC) visits, with the Pakistani site having only 40% of women who had at least four ANC visits. Maternal hypertensive disorders were reported to be more common in the Asian and Guatemalan sites and lower in the African sites.
Severe antepartum hemorrhage was less than 0.6% in all sites except the Pakistani site (1.5%) and fetal malpresentation was 0.7% or less in the African sites, but between 1.6% and 2.9% in the Asian and Guatemalan sites.

Rates of preterm birth, LBW and preterm birth and LBW

Figure 2a shows the rates of preterm birth, LBW, the combination of preterm birth and LBW as well as term, normal birth weight live births. The overall rate of preterm birth across the GN sites was 12.6%. As shown in Fig. 2a, among the Asian sites, preterm birth rates were the highest in the Pakistani site (21.8%) and lowest for the Belagavi site (8.6%). Among the African sites, DRC had the highest preterm birth rate of 18.3%. The overall LBW rate was 13.6%, in the African sites ranging from 2.7% (Kenyan site) to 9.5% (DRC site), and in the Asian sites from 17.3% (Nagpur site) to 21.4% (Pakistani site). Figure 2a also shows the rates of babies with a combination of preterm birth and LBW at 5.5%. Of note, the very low birth weight rate (those weighing < 1500 gm), was observed in 0.6% of the births overall, ranging from 0.2% in the Kenyan site to 1.1% in the Pakistani site.
Figure 2b displays the variations across sites in the proportions of LBW babies who were preterm vs. term with the Indian sites and the Guatemalan site having higher percent of term LBW babies.

Risk factors associated with preterm birth, LBW and preterm birth and LBW

Risk factors associated with preterm Birth

As shown in Fig. 3, factors associated with increased risk of preterm birth in most (at least 4 of the 7 sites) GN sites included younger maternal age < 20 years, no formal education, no receipt of antenatal iron, calcium or vitamins, less than four ANC visits, severe antepartum hemorrhage, maternal hypertensive disorders, and fetal malpresentation. Of note, female gender and nulliparity was associated with preterm births at the African sites but not in the Asian sites or the Guatemalan site. Obstructed labor was associated with a decreased risk for preterm birth at most sites (see Table 2).
Table 2
Maternal, delivery and infant characteristics as risk factors for preterm birth—overall and site-specific risk ratios with 95% confidence intervals and p values
Characteristic
Relative risk (95% CI), p-value
Overall, all sites
DRC
Zambia
Kenya
Guatemala
Belagavi
Nagpur
Pakistan
Maternal age (20–35)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 < 20
1.31 (1.26,1.37), < .0001
1.45 (1.30, 1.63), < .0001
1.36 (1.28, 1.44), < .0001
1.51 (1.40, 1.62), < .0001
1.30 (1.22, 1.38), < .0001
1.09 (0.99, 1.20), 0.0880
1.25 (1.07, 1.47), 0.0061
1.05 (0.93, 1.20), 0.4115
 > 35
1.07 (1.02,1.12), 0.0078
1.08 (1.00, 1.18), 0.0636
1.13 (1.02, 1.25), 0.0196
1.05 (0.93, 1.19), 0.3893
1.13 (1.02, 1.24), 0.0151
2.22 (1.56, 3.16), < .0001
1.00 (0.68, 1.49), 0.9847
0.94 (0.86, 1.03), 0.1647
Maternal education (University+)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 No formal education
1.32 (1.23,1.41), < .0001
2.30 (1.01, 5.25), 0.0474
1.77 (1.46, 2.14), < .0001
1.48 (1.04, 2.09), 0.0294
1.18 (0.97, 1.44), 0.0969
1.29 (1.11, 1.48), 0.0006
1.50 (1.27, 1.77), < .0001
1.13 (0.94, 1.35), 0.1895
 Primary/secondary
1.17 (1.11,1.23), < .0001
2.20 (0.94, 5.14), 0.0684
1.57 (1.26, 1.95), < .0001
1.23 (1.08, 1.40), 0.0013
1.07 (0.91, 1.25), 0.4209
1.01 (0.92, 1.12), 0.7693
1.39 (1.27, 1.52), < .0001
1.01 (0.86, 1.18), 0.9492
Parity (1–2)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 0
1.12 (1.07, 1.16), < .0001
1.49 (1.37, 1.62), < .0001
1.13 (1.05, 1.23), 0.0018
1.39 (1.25, 1.55), < .0001
1.00 (0.94, 1.06), 0.9133
1.10 (0.98, 1.24), 0.0944
1.05 (0.98, 1.12), 0.1429
0.98 (0.92, 1.05), 0.5708
 > 2
0.93 (0.89, 0.97), 0.0002
0.95 (0.88, 1.02), 0.1329
0.95 (0.88, 1.03), 0.2046
1.11 (1.03, 1.19), 0.0045
0.94 (0.87, 1.02), 0.1227
1.07 (0.96, 1.19), 0.2446
1.31 (1.04, 1.65), 0.0243
0.87 (0.82, 0.92), < .0001
Consumption of vitamins/calcium/iron
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Not consumed
1.18 (1.11, 1.25), < .0001
1.33 (1.20, 1.47), < .0001
1.24 (0.59, 2.61), 0.5700
1.46 (1.07, 2.00), 0.0178
1.10 (0.98, 1.23), 0.1168
1.78 (1.53, 2.08), < .0001
1.29 (0.86, 1.93), 0.2139
1.06 (1.03, 1.10), 0.0006
Received tetanus toxoid immunization
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Did not receive
1.08 (1.02, 1.14), 0.0050
1.15 (0.99, 1.32), 0.0656
0.90 (0.75, 1.07), 0.2436
1.10 (0.96, 1.27), 0.1796
0.96 (0.88, 1.05), 0.3776
0.89 (0.30,2.64), 0.8286
1.39 (0.98,1.97), 0.0680
1.12 (1.07,1.18), < .0001
Number of ANC visits (4+)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 0
1.66 (1.46, 1.88), < .0001
2.42 (1.90, 3.07), < .0001
3.97 (1.61, 9.77), 0.0027
3.28 (2.58, 4.15), < .0001
1.17 (1.02, 1.34), 0.0217
2.33 (0.89, 6.14), 0.0856
0.42 (0.17, 1.03), 0.0590
1.30 (1.14, 1.47), < .0001
 1–3
1.65 (1.54, 1.78), < .0001
2.14 (1.85, 2.47), < .0001
2.48 (2.05, 3.00), < .0001
2.04 (1.85, 2.24), < .0001
1.52 (1.43, 1.63), < .0001
1.83 (1.61, 2.08), < .0001
1.30 (1.08, 1.56), 0.0050
1.16 (1.11, 1.21), < .0001
No obstructive labor
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had obstructive labor
0.77 (0.72, 0.82), < .0001
0.88 (0.77, 1.00), 0.0417
0.97 (0.77, 1.20), 0.7559
0.82 (0.68, 0.99), 0.0405
0.67 (0.53, 0.83), 0.0004
0.80 (0.65, 0.97), 0.0255
0.70 (0.60, 0.81), < .0001
0.75 (0.68, 0.83),< .0001
No severe antepartum hemorrhage
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had severe antepartum hemorrhage
2.81 (2.49, 3.18), < .0001
2.54 (1.94, 3.32),< .0001
2.89 (1.99, 4.21), < .0001
1.97 (1.50, 2.57), < .0001
4.66 (3.80, 5.72), < .0001
5.63 (4.80, 6.60), < .0001
5.19 (4.17, 6.45), < .0001
1.92 (1.76, 2.09), < .0001
No severe postpartum hemorrhage
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had severe postpartum hemorrhage
0.93 (0.84, 1.02), 0.1369
0.91 (0.65, 1.27), 0.5680
1.01 (0.69, 1.47), 0.9742
1.11 (0.93, 1.34), 0.2493
1.24 (0.93, 1.67), 0.1460
0.96 (0.78, 1.18), 0.6729
1.52 (0.83, 2.77), 0.1721
0.81 (0.74, 0.89), < .0001
No hypertensive disorders
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had hypertensive disorders
1.81 (1.68, 1.95), < .0001
2.12 (1.43, 3.15), 0.0002
1.79 (1.18, 2.72), 0.0062
1.95 (1.32, 2.87), 0.0008
1.95 (1.76, 2.17), < .0001
2.52 (2.30,2.77), < .0001
2.30 (2.05,2.57), < .0001
1.19 (1.05,1.35), 0.0075
No fetal malpresentation
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had fetal malpresentation
1.35 (1.26, 1.45), < .0001
1.31 (0.81, 2.09), 0.2679
1.53 (1.20, 1.97), 0.0007
1.11 (0.81, 1.53), 0.5165
1.44 (1.28, 1.62), < .0001
1.65 (1.26,2.15), 0.0002
0.99 (0.81,1.22), 0.9594
1.34 (1.20,1.50), < .0001
BMI, kg/m2 (18.5–24.9)
1.0
1.0
1.0
 
1.0
1.0
1.0
1.0
 < 18.5
1.18 (1.15, 1.22), < .0001
1.20 (1.12, 1.28), < .0001
1.19 (1.03, 1.39), 0.0213
1.22 (0.98, 1.53), 0.0779
1.26 (1.16, 1.37), < .0001
1.18 (1.10, 1.26), < .0001
1.18 (1.11, 1.25), < .0001
 ≥ 25.0
0.80 (0.77, 0.83), < .0001
0.73 (0.63, 0.84), < .0001
0.79 (0.73, 0.85), < .0001
0.78 (0.73, 0.83), < .0001
1.14 (1.00, 1.29), 0.0529
0.82 (0.68, 0.98), 0.0336
0.78 (0.72, 0.85), < .0001
Hemoglobin (≥ 11 g/dL)
1.0
    
1.0
1.0
 
 10.0–10.9 g/dL (mild)
0.97 (0.90, 1.04), 0.3626
0.92 (0.82, 1.02), 0.1119
1.04 (0.97, 1.12), 0.2950
 < 10.0 g/dL (moderate/severe)
1.10 (1.04, 1.17), 0.0013
1.04 (0.97, 1.12), 0.3015
1.20 (1.10, 1.30), < .0001
Sex of the baby (male)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Female
1.03 (1.01, 1.06), 0.0055
1.14 (1.08, 1.20), < .0001
1.16 (1.11, 1.21), < .0001
1.10 (1.05, 1.15), < .0001
0.94 (0.92, 0.97), < .0001
0.87 (0.82, 0.92), < .0001
1.00 (0.95, 1.06), 0.9464
1.03 (1.00, 1.07), 0.0812
□—BMI not calculated for Kenya because maternal height was not recorded before 2017
░—maternal hemoglobin not consistently collected at all GN sites except Belagavi, India and Nagpur, India
Generalized linear models were used to evaluate the relationship of potential factors and prematurity and to develop point and interval estimates of relative risk associated with these factors. Generalized estimating equations were used to account for the correlation of outcomes within cluster to develop appropriate confidence intervals. The reference group is indicated by 1.0 in the Risk Ratio column

Risk factors associated with LBW

Figure 3 shows that the overall risk factors for LBW were similar to the risk factors for preterm birth. As shown in Table 3, the risk factors for LBW included maternal age < 20 years, no formal education or only primary and secondary education, nulliparity, no receipt of iron, calcium or vitamins, less than four ANC visits, severe antepartum hemorrhage, maternal hypertensive disorders and fetal malpresentation. Female neonates were more likely to be LBW in all sites.
Table 3
Maternal, delivery and infant characteristics as risk factors for low birth weight—overall and site specific risk ratios with 95% confidence intervals and p values
Characteristic
Relative risk (95% CI), p-value
Overall, all sites
DRC
Zambia
Kenya
Guatemala
Belagavi
Nagpur
Pakistan
Maternal age (20–35)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 < 20
1.35 (1.30, 1.40), < .0001
1.84 (1.60, 2.10), < .0001
1.67 (1.49, 1.88), < .0001
2.31 (2.10, 2.55), < .0001
1.23 (1.17, 1.28), < .0001
1.33 (1.27, 1.39), < .0001
1.23 (1.11, 1.36), < .0001
1.40 (1.27, 1.54), < .0001
 > 35
1.00 (0.95, 1.05), 0.8649
1.24 (1.04, 1.49), 0.0177
0.98 (0.80, 1.21), 0.8748
0.71 (0.49, 1.02), 0.0655
1.01 (0.95, 1.07), 0.7819
1.53 (1.22, 1.91), 0.0002
1.35 (1.01, 1.79), 0.0392
0.82 (0.73, 0.91), 0.0002
Maternal education (University +)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 No formal education
1.31 (1.23, 1.38), < .0001
4.56 (1.56, 13.33), 0.0056
0.76 (0.60, 0.95), 0.0158
1.21 (0.78, 1.86), 0.3961
1.16 (1.08, 1.25), < .0001
1.39 (1.24, 1.55), < .0001
1.11 (0.95, 1.30), 0.1952
1.31 (1.12, 1.53), 0.0009
 Primary/secondary
1.21 (1.15, 1.27), < .0001
4.38 (1.49, 12.83), 0.0072
0.88 (0.76, 1.02), 0.0896
0.91 (0.74, 1.13), 0.4152
1.16 (1.08, 1.24), < .0001
1.21 (1.10, 1.33), < .0001
1.26 (1.16, 1.36), < .0001
1.11 (0.90, 1.36), 0.3342
Parity (1–2)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 0
1.38 (1.34,1.43), < .0001
1.86 (1.69,2.05), < .0001
1.57 (1.42,1.74), < .0001
2.23 (1.93,2.59), < .0001
1.26 (1.20,1.32), < .0001
1.41 (1.34, 1.50), < .0001
1.38 (1.32, 1.45), < .0001
1.23 (1.16, 1.31), < .0001
 > 2
0.90 (0.87, 0.93), < .0001
0.86 (0.79, 0.94), 0.0007
0.90 (0.83, 0.99), 0.0264
0.78 (0.67, 0.91), 0.0015
0.93 (0.87, 0.99), 0.0148
0.91 (0.85, 0.98), 0.0114
1.01 (0.86, 1.19), 0.8745
0.85 (0.80, 0.89), < .0001
Consumption of vitamins/calcium/iron
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Not consumed
1.18 (1.10, 1.27), < .0001
1.35 (1.11, 1.64), 0.0030
2.20 (0.99, 4.89), 0.0521
1.71 (1.14, 2.58), 0.0100
1.16 (0.98, 1.36), 0.0779
1.47 (1.34, 1.62), < .0001
0.81 (0.60, 1.10), 0.1811
1.10 (1.03, 1.17), 0.0027
Received tetanus toxoid immunization
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Did not receive
1.03 (0.97, 1.09), 0.3134
1.15 (0.90, 1.46), 0.2625
0.66 (0.48, 0.91), 0.0122
0.73 (0.52, 1.03), 0.0706
0.93 (0.87, 0.98), 0.0146
0.85 (0.53, 1.36), 0.5044
0.89 (0.61, 1.31), 0.5602
1.14 (1.07, 1.21), < .0001
Number of ANC visits (4+)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 0
1.36 (1.20, 1.55), < .0001
2.48 (1.83, 3.35), < .0001
6.45 (3.12, 13.33), < .0001
2.90 (2.00, 4.20), < .0001
1.20 (0.96, 1.50), 0.1003
1.26 (0.53, 2.98), 0.5976
0.65 (0.44, 0.95), 0.0277
1.25 (1.09, 1.44), 0.0015
 1–3
1.27 (1.22, 1.31), < .0001
1.88 (1.58, 2.25), < .0001
1.70 (1.39, 2.07), < .0001
1.48 (1.28, 1.70), < .0001
1.23 (1.18, 1.28), < .0001
1.33 (1.26, 1.41), < .0001
1.08 (1.00, 1.16), 0.0399
1.15 (1.08, 1.22), < .0001
No obstructive labor
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had obstructive labor
0.85 (0.80, 0.92), < .0001
1.30 (1.05, 1.60), 0.0151
1.24 (0.85, 1.81), 0.2691
1.21 (0.85, 1.72), 0.2813
0.71 (0.60, 0.84), < .0001
0.90 (0.79, 1.02), 0.1106
0.82 (0.74, 0.91), 0.0002
0.88 (0.80, 0.96), 0.0042
No severe antepartum hemorrhage
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had severe antepartum hemorrhage
2.82 (2.53, 3.15), < .0001
4.89 (3.63, 6.59), < .0001
6.56 (5.09, 8.45), < .0001
5.70 (3.93, 8.27), < .0001
3.63 (3.18, 4.14), < .0001
3.22 (2.74,3.80), < .0001
3.05 (2.43, 3.81), < .0001
1.89 (1.73, 2.07), < .0001
No severe postpartum hemorrhage
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had severe postpartum hemorrhage
1.02 (0.93, 1.12), 0.6406
1.10 (0.79, 1.53), 0.5741
1.36 (0.94, 1.97), 0.1036
2.32 (1.36, 3.97), 0.0021
1.15 (0.95, 1.38), 0.1438
0.89 (0.79, 1.01), 0.0805
1.06 (0.70, 1.60), 0.7964
0.96 (0.86, 1.07), 0.4937
No hypertensive disorders
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had hypertensive disorders
2.01 (1.88, 2.15), < .0001
1.72 (0.87, 3.40), 0.1185
3.52 (2.57, 4.82), < .0001
6.35 (3.84, 10.50), < .0001
1.99 (1.83, 2.16), < .0001
1.98 (1.86, 2.11), < .0001
1.93 (1.73, 2.14), < .0001
1.31 (1.16, 1.47), < .0001
No fetal malpresentation
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had fetal malpresentation
1.45 (1.35, 1.56), < .0001
2.43 (1.44, 4.08), 0.0008
2.25 (1.49, 3.39), 0.0001
2.13 (1.02, 4.44), 0.0432
1.40 (1.25, 1.56), < .0001
1.38 (1.16, 1.63), 0.0002
1.28 (1.09, 1.49), 0.0022
1.41 (1.28, 1.56), < .0001
BMI, kg/m2 (18.5–24.9)
1.0
1.0
1.0
 
1.0
1.0
1.0
1.0
 < 18.5
1.30 (1.26, 1.34), < .0001
1.54 (1.44, 1.64), < .0001
1.45 (1.19, 1.76), 0.0002
1.43 (1.22, 1.66), < .0001
1.22 (1.18, 1.26), < .0001
1.24 (1.18, 1.30), < .0001
1.36 (1.31, 1.42), < .0001
≥ 25.0
0.70 (0.67, 0.73), < .0001
0.68 (0.59, 0.78), < .0001
0.57 (0.51, 0.64), < .0001
0.68 (0.65, 0.72), < .0001
0.80 (0.74, 0.87), < .0001
0.77 (0.69, 0.86) < .0001
0.70 (0.64, 0.76), < .0001
Hemoglobin (≥ 11 g/dL)
1.0
    
1.0
1.0
 
 10.0–10.9 g/dL (mild)
1.02 (0.98, 1.06), 0.2489
1.00 (0.96, 1.05), 0.9940
1.07 (1.01, 1.13), 0.0187
 < 10.0 g/dL (moderate/severe)
1.12 (1.08, 1.17), < .0001
1.08 (1.03,1.14), 0.0035
1.20 (1.14, 1.26), < .0001
Sex of the baby (male)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Female
1.19 (1.17, 1.21), < .0001
1.24 (1.16, 1.31), < .0001
1.19 (1.09, 1.30), < .0001
1.15 (1.01, 1.31), 0.0296
1.24 (1.19, 1.28), < .0001
1.16 (1.11, 1.21), < .0001
1.20 (1.16, 1.24), < .0001
1.17 (1.12, 1.23), < .0001
□—BMI not calculated for Kenya because maternal height was not recorded before 2017
░—Maternal hemoglobin not consistently collected at all GN sites except Belagavi, India and Nagpur, India
Generalized linear models were used to evaluate the relationship of potential factors and LBW and to develop point and interval estimates of relative risk associated with these factors. Generalized estimating equations were used to account for the correlation of outcomes within cluster to develop appropriate confidence intervals. The reference group is indicated by 1.0 in the Risk Ratio column

Risk factors associated with both preterm birth and LBW

Figure 3 shows that the risk factors for having both a LBW and preterm birth were similar to having either a preterm or LBW birth.
However, the effect size of the antenatal care, antepartum hemorrhage and hypertensive disorder risk factors were higher than for preterm birth or LBW alone (see Table 4).
Table 4
Maternal, delivery and infant characteristics as risk factors for preterm birth and low birth weight—overall and site specific risk ratios with 95% confidence intervals and p values
Characteristic
Relative risk (95% CI), p-value
Overall, all sites
DRC
Zambia
Kenya
Guatemala
Belagavi
Nagpur
Pakistan
Maternal age (20–35)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 < 20
1.41 (1.32, 1.49), < .0001
1.94 (1.61, 2.33), < .0001
1.68 (1.48, 1.90), < .0001
2.38 (2.08, 2.72), < .0001
1.32 (1.22, 1.42), < .0001
1.16 (1.06, 1.28), 0.0024
1.35 (1.11, 1.65), 0.0026
1.30 (1.15, 1.48), < .0001
 > 35
1.08 (1.00, 1.17), 0.0385
1.23 (1.02, 1.48), 0.0305
1.10 (0.89, 1.35), 0.3785
0.46 (0.19, 1.07), 0.0724
1.19 (1.05, 1.35), 0.0057
2.18 (1.48, 3.22), < .0001
1.35 (0.87, 2.10), 0.1758
0.91 (0.78, 1.07), 0.2510
Maternal education (University +)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 No formal education
1.28 (1.18, 1.38), < .0001
 
0.67 (0.54, 0.83), 0.0002
0.95 (0.49, 1.82), 0.8741
1.08 (0.89, 1.30), 0.4399
1.26 (1.10, 1.45), 0.0008
1.32 (1.06, 1.65), 0.0140
1.25 (1.04, 1.50), 0.0165
 Primary/secondary
1.13 (1.06, 1.21), 0.0002
 
0.78 (0.64, 0.96), 0.0201
0.93 (0.64, 1.35), 0.6876
1.11 (0.96, 1.27), 0.1620
0.98 (0.88, 1.08), 0.6455
1.39 (1.23, 1.57), < .0001
1.07 (0.87, 1.32), 0.5037
Parity (1–2)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 0
1.27 (1.21, 1.33), < .0001
1.95 (1.69, 2.25), < .0001
1.46 (1.36, 1.57), < .0001
2.14 (1.79, 2.57), < .0001
1.14 (1.03, 1.27), 0.0122
1.22 (1.08, 1.39), 0.0014
1.26 (1.16, 1.36), < .0001
1.12 (1.05, 1.20), 0.0010
 > 2
0.90 (0.86, 0.95), < .0001
0.92 (0.84, 1.01), 0.0822
0.90 (0.80, 1.03), 0.1159
0.69 (0.58, 0.82), < .0001
0.99 (0.87, 1.12), 0.8555
1.08 (0.99, 1.18), 0.0977
1.43 (1.03, 1.99), 0.0349
0.85 (0.79, 0.91), < .0001
Consumption of vitamins/calcium/iron
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Not consumed
1.30 (1.15, 1.47), < .0001
1.82 (1.44, 2.31), < .0001
2.94 (0.89, 9.77), 0.0783
1.90 (0.91, 3.95), 0.0875
1.22 (1.03, 1.45), 0.0227
2.17 (1.91, 2.46), < .0001
0.72 (0.29, 1.75), 0.4654
1.08 (1.01, 1.16), 0.0357
Received tetanus toxoid immunization
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Did not receive
1.13 (1.04, 1.23), 0.0030
1.39 (1.03, 1.86), 0.0294
0.67 (0.43, 1.05), 0.0806
0.75 (0.48, 1.16), 0.1939
0.92 (0.84, 1.01), 0.0664
0.57 (0.09, 3.54), 0.5503
1.15 (0.56, 2.39), 0.7008
1.23 (1.14, 1.33), < .0001
Number of ANC visits (4 +)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 0
1.88 (1.56, 2.27), < .0001
5.27 (3.76, 7.39), < .0001
15.00 (6.23, 36.10), < .0001
5.93 (4.06, 8.68), < .0001
1.29 (1.03, 1.60), 0.0257
3.14 (1.15, 8.54), 0.0252
0.35 (0.14, 0.87), 0.0234
1.32 (1.12, 1.55), 0.0007
 1–3
1.68 (1.55, 1.83), < .0001
3.17 (2.57, 3.91), < .0001
3.00 (2.22, 4.06), < .0001
2.62 (2.09, 3.29), < .0001
1.59 (1.47, 1.72), < .0001
2.13 (1.87, 2.44), < .0001
1.40 (1.12, 1.75), 0.0030
1.16 (1.09, 1.24), < .0001
No obstructive labor
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had obstructive labor
0.78 (0.70, 0.87), < .0001
1.51 (1.20, 1.89), 0.0004
1.28 (0.84, 1.97), 0.2551
1.71 (1.19, 2.44), 0.0036
0.59 (0.43, 0.82), 0.0018
0.76 (0.59, 0.97), 0.0251
0.68 (0.56, 0.84), 0.0002
0.79 (0.71, 0.88), < .0001
No severe antepartum hemorrhage
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had severe antepartum hemorrhage
5.18 (4.44, 6.04), < .0001
6.63 (5.04, 8.72), < .0001
10.24 (7.15, 14.66) < .0001
10.28 (6.29, 16.77), < .0001
8.52 (6.99, 10.40), < .0001
7.40 (6.22, 8.81), < .0001
8.00 (6.16, 10.38), < .0001
2.75 (2.44, 3.11), < .0001
No severe postpartum hemorrhage
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had severe postpartum hemorrhage
1.22 (1.07, 1.40), 0.0035
1.10 (0.68, 1.77), 0.6996
1.67 (1.16, 2.42), 0.0062
3.42 (2.14, 5.46), < .0001
1.80 (1.31, 2.49), 0.0003
1.18 (0.97, 1.43), 0.0980
1.70 (0.90,3.20), 0.0996
0.96 (0.85,1.09), 0.5243
No hypertensive disorders
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had hypertensive disorders
2.74 (2.48, 3.02), < .0001
2.64 (1.17, 5.96), 0.0193
4.54 (2.82, 7.31), < .0001
10.72 (5.60, 20.51), < .0001
2.84 (2.52, 3.19), < .0001
3.09 (2.77, 3.44), < .0001
3.18 (2.80, 3.61), < .0001
1.46 (1.25, 1.72), < .0001
No fetal malpresentation
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Had fetal malpresentation
1.74 (1.56, 1.93), < .0001
2.93 (1.68, 5.13), 0.0002
2.62 (1.58, 4.35), 0.0002
3.50 (1.90, 6.47), < .0001
1.80 (1.48, 2.19), < .0001
1.83 (1.42, 2.35), < .0001
1.17 (0.92, 1.50), 0.1985
1.57 (1.38, 1.78), < .0001
BMI, kg/m2 (18.5–24.9)
1.0
1.0
1.0
 
1.0
1.0
1.0
1.0
 < 18.5
1.33 (1.27, 1.39), < .0001
1.40 (1.28, 1.53), < .0001
1.39 (1.20, 1.62), < .0001
1.42 (1.07, 1.88), 0.0139
1.26 (1.16, 1.38), < .0001
1.28 (1.15, 1.42), < .0001
1.40 (1.31, 1.50), < .0001
 ≥ 25.0
0.77 (0.72, 0.81), <.0001
0.68 (0.57, 0.80), < .0001
0.61 (0.54, 0.68), < .0001
0.73 (0.66, 0.81), < .0001
1.12 (0.95, 1.33), 0.1603
0.82 (0.63, 1.07), 0.1503
0.76 (0.69, 0.84), < .0001
Hemoglobin (≥ 11 g/dL)
1.0
    
1.0
1.0
 
 10.0–10.9 g/dL (mild)
0.96 (0.87, 1.05), 0.3580
0.93 (0.82, 1.05), 0.2182
1.04 (0.89, 1.23), 0.6142
 < 10.0 g/dL (moderate/severe)
1.12 (1.02, 1.23), 0.0137
1.08 (0.97, 1.21), 0.1754
1.25 (1.07, 1.46), 0.0046
Sex of the baby (MALE)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 Female
1.01 (0.98, 1.04), 0.5527
1.18 (1.09, 1.28), < .0001
1.13 (1.08, 1.19), < .0001
1.00 (0.88, 1.13), 0.9487
0.94 (0.88, 0.99), 0.0236
0.86 (0.81, 0.92), < .0001
1.00 (0.94, 1.07), 0.9333
1.07 (1.01, 1.15), 0.0338
□—BMI not calculated for Kenya because maternal height was not recorded before 2017
░—maternal hemoglobin not consistently collected at all GN sites except Belagavi, India and Nagpur, India
Generalized linear models were used to evaluate the relationship of potential factors and the combination of prematurity and LBW and to develop point and interval estimates of relative risk associated with these factors. Generalized estimating equations were used to account for the correlation of outcomes within cluster to develop appropriate confidence intervals. The reference group is indicated by 1.0 in the Risk Ratio column

Risk factors available at select sites

Maternal BMI was available in all sites except the Kenya site. BMI < 18.5 kg/m2 was a risk factor for preterm birth at all sites and LBW at nearly all sites. Maternal hemoglobin was consistently available over the study period in the two Indian sites. Mild anemia (hemoglobin 10.0–10.9 g/dL) was associated only with LBW in the Nagpur site and not associated with preterm at either of the sites. Moderate to severe anemia (< 10 g/dL) was associated with preterm birth, LBW, and the combination of preterm birth and LBW when data from the two Indian sites were combined.

Discussion

The Global Network’s population-based estimate of the preterm birth rate was 12.6% with the highest rates in the Pakistani and the DRC sites and the lowest rates (< 10%) in the Indian and Kenyan sites. LBW rates were 13.6% but showed a different pattern with the highest rates in the Asian and Guatemalan sites and the lowest rates in the African sites. The combination of preterm birth and LBW was highest in the Pakistani site (11%) and lowest in the Kenyan site (1.2%).
Our rural and semi-urban population rates for preterm birth are similar to country-wide estimates in previously reported studies [2328]. However, our results are higher than recent global estimates for preterm birth in 2014 (10.6%—uncertainty interval 9.0–12.0) [7]. Rates of preterm birth in the Pakistani and DRC sites were outliers among the GN sites and were associated with poor antenatal care indicators such as lack of receipt of antenatal iron, calcium and vitamins, lack of tetanus toxoid immunization and fewer than four antenatal visits [2931]. The Asian sites had higher rates of LBW, likely because term and preterm birth weights are higher in the African sites and intrauterine growth retardation or SGA is more common in the Asian sites as observed in other studies [3236].
Our estimates of LBW are slightly lower, but within range of recent global estimates for LBW in 2015 (14.6%—uncertainty range 12.4–17.1%) [8]. To our knowledge, there are no prior global estimates of the combination of both preterm and LBW. Risk factors for having a preterm birth and LBW baby are similar to those for each condition alone, likely because of the overlap of these outcomes. They include poor ANC indicators such as less than four ANC visits, nulliparity and maternal age under age 20 [37], severe antepartum hemorrhage and hypertensive disorders. The similarity of risk factors for preterm birth, LBW and the combination of preterm birth and LBW in the GN sites suggest an important need to monitor those women with these risk factors as it may help to improve their pregnancy outcomes.
Risk factors for prematurity, LBW and their combination varied by GN site. Therefore, the antenatal factors that are associated with these neonatal conditions may be monitored according to their region. The African sites had higher rates of preterm birth in the nulliparous women, whereas parity was not associated with preterm birth in the other GN sites. This was perhaps due to the higher proportion of women in Africa being < 20 years of age and likely to have their first pregnancy at younger ages [31, 37]. The other factor that was associated with increased risk for preterm birth in all sites was antepartum hemorrhage [38, 39]. The rates of preterm births were higher in the African sites. Whereas the rates of LBW were much higher in the non-African sites and so were the reported rates of hypertensive disorders. Hypertensive disorders are associated with SGA [40]. Another possible reason for higher rates of LBW in Asian sites could be higher rates of BMI < 18.5 kg/m2 and its association with LBW [41]. Moderate/severe anemia recorded anytime during pregnancy (data evaluated only for the Indian sites where enrollment in the study tended to be earlier in pregnancy than in other sites), either due to iron deficiency or other causes, increased the risk of both preterm birth and LBW. Anemia any time and especially during the rapid fetal growth during the third trimester is reported as an important factor in determining birth weight [1820].
Another interesting observation from this study was the association of gender of the newborn with preterm birth and LBW. In African sites, female newborns were more likely to be preterm. Although reported previously the reasons for this finding are unclear [42, 43]. At all sites, the rate of LBW in female newborns was more than in males.
The strengths of our study are that it is a population-based assessment of the burden of preterm birth and LBW across different LMIC community sites and their risk factors that differ by site indicating that further exploration of association of these risk factors may help to tailor public health strategies. The GN uses uniform and rigorous criteria across sites for assessment of gestational age, increasingly based on ultrasound dating (particularly first trimester) to improve precision of estimates of preterm birth rates. The GN has also focused on accurate estimation of measured birth weight within 6 days of birth in approximately 99% of neonates, to avoid rounding errors and delayed reporting of birth weight [15]. Missing values of key variables including birthweight are minimal, particularly as a result of increased institutional deliveries.
Limitations of the study include the population under study – it is not countrywide, because it is based on access to a rural and semi-urban population. Another limitation is that while estimation of gestational age and therefore preterm birth rates are improving, they are not yet optimal.
LMP may not be a reliable indicator in this population due to recall bias and inability to remember the exact LMP by less educated individuals. Even when the LMP is known, there is a risk for potential bias as the estimation of LMP is based on the assumption of a uniform 28-day cycle with ovulation on day 14 of that cycle, both of which may not necessarily be true, especially if contraceptives have been used before conception [4446]. There can be a lack of agreement on the definition (women estimate the LMP as the last day of the menstrual period) of LMP between the doctor and pregnant woman. This can lead to errors and discrepancies in GA assessment by LMP [47]. Ultrasound dating is also limited by the changes in the size of the fetus which is not uniform throughout the pregnancy. It does not account for growth restriction and thus can lead to misclassification of term growth restricted baby as a preterm birth [48]. The magnitude and direction of the systematic bias should be considered while using the US based estimates. Increased access to high quality ultrasound estimates early in pregnancy is likely to further improve precision of preterm birth estimates. Improved precision of gestational age will allow estimation of growth restriction at all gestational ages (SGA). Rates of SGA and its determinants at each site were not estimated in this analysis. So further research is needed to understand the risk factors of SGA and how they differ at each site, when better estimates of gestational age become available.
Additionally, the association of plausible risk factors like socio-economic status, income, history or previous preterm as well as modifiable risk factors should be accounted for in the future research.

Conclusion

Rates of preterm births, LBWs and their combination remain high at the GN sites. Prominent risk factors that were similar across sites included nulliparity, maternal age under 20 years, less than 4 antenatal care visits, severe antenatal hemorrhage, and hypertensive disease.
While all pregnancies need care and consideration to prevent preterm births, the younger nulliparous women who may have received limited access to ANC services and so are at higher risk for preterm births need more attention to prevent prematurity and LBW.

Acknowledgements

We thank all the study staff involved in collection of the data analyzed in this work and all the women who participated in the study—their health, well-being, and successful pregnancy outcomes are the motivation for performing this work. We acknowledge the efforts of statisticians from the Lata Medical Research Foundation Ms. Preeti Kawadkar and Ms. Nilima Bansod for their help with developing the figures for the study.

About this supplement

This article has been published as part of Reproductive Health, Volume 17 Supplement 3, 2020: Global Network MNH. The full contents of the supplement are available at https://​reproductive-health-journal.​biomedcentral.​com/​articles/​supplements/​volume-17-supplement-3.
The appropriate institutional review boards/ethics research committees of the participating institutions approved the MNHR study. Individual informed consent for study participation is requested and obtained from each study participant. A Data Monitoring Committee, appointed by the NICHD, oversees and reviews the study semi-annually.

Competing interests

The authors have no relationships to disclose that may be deemed to influence the objectivity of this paper and its review. The authors report no commercial associations, either directly or through immediate family, in areas such as expert testimony, consulting, honoraria, stock holdings, equity interest, ownership, patent-licensing situations or employment that might pose a conflict of interest to this analysis. Additionally, the authors have no conflicts such as personal relationships or academic competition to disclose. The findings presented in this paper represent the views of the named authors only, and not the views of their institutions or organizations.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
3.
Zurück zum Zitat Katz J, Lee AC, Kozuki N, Lawn JE, Cousens S, Blencowe H, et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet. 2013;382(9890):417–25. CrossRef Katz J, Lee AC, Kozuki N, Lawn JE, Cousens S, Blencowe H, et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet. 2013;382(9890):417–25. CrossRef
4.
Zurück zum Zitat Lee AC, Katz J, Blencowe H, Cousens S, Kozuki N, Vogel JP, et al. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob Health. 2013;1(1):e26-36. CrossRef Lee AC, Katz J, Blencowe H, Cousens S, Kozuki N, Vogel JP, et al. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob Health. 2013;1(1):e26-36. CrossRef
5.
Zurück zum Zitat Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller A-B, et al. Born too soon: The global epidemiology of 15 million preterm births. Reprod Health. 2013;10(Suppl 1):S2. CrossRef Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller A-B, et al. Born too soon: The global epidemiology of 15 million preterm births. Reprod Health. 2013;10(Suppl 1):S2. CrossRef
6.
Zurück zum Zitat Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388(10063):3027–35. CrossRef Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388(10063):3027–35. CrossRef
7.
Zurück zum Zitat Sania A, Smith ER, Manji K, Duggan C, Masanja H, Kisenge R, et al. Neonatal and infant mortality risk associated with preterm and small for gestational age births in Tanzania: individual level pooled analysis using the intergrowth standard. J Pediatrics. 2018;192:66–72. CrossRef Sania A, Smith ER, Manji K, Duggan C, Masanja H, Kisenge R, et al. Neonatal and infant mortality risk associated with preterm and small for gestational age births in Tanzania: individual level pooled analysis using the intergrowth standard. J Pediatrics. 2018;192:66–72. CrossRef
8.
Zurück zum Zitat Chawanpaiboon S, Vogel JP, Moller A-B, Lumbiganon P, Petzold M, Hogan D, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7(1):e37-46. CrossRef Chawanpaiboon S, Vogel JP, Moller A-B, Lumbiganon P, Petzold M, Hogan D, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7(1):e37-46. CrossRef
9.
Zurück zum Zitat Blencowe H, Krasevec J, de Onis M, Black RE, An X, Stevens GA, et al. National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis. Lancet Glob Health. 2019;7(7):e849–60. CrossRef Blencowe H, Krasevec J, de Onis M, Black RE, An X, Stevens GA, et al. National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis. Lancet Glob Health. 2019;7(7):e849–60. CrossRef
10.
Zurück zum Zitat Rüegger C, Hegglin M, Adams M, Bucher HU. Swiss Neonatal Network. Population based trends in mortality, morbidity and treatment for very preterm- and very low birth weight infants over 12 years. BMC Pediatr. 2012;12:17. CrossRef Rüegger C, Hegglin M, Adams M, Bucher HU. Swiss Neonatal Network. Population based trends in mortality, morbidity and treatment for very preterm- and very low birth weight infants over 12 years. BMC Pediatr. 2012;12:17. CrossRef
11.
Zurück zum Zitat Garcés A, MacGuire E, Franklin H, Alfaro N, Arroyo G, Figueroa L et al. Looking Beyond the numbers: quality assurance procedures in the global network for women´s and children’s health research Maternal Newborn Health Registry. BMC Supp; 2020 Garcés A, MacGuire E, Franklin H, Alfaro N, Arroyo G, Figueroa L et al. Looking Beyond the numbers: quality assurance procedures in the global network for women´s and children’s health research Maternal Newborn Health Registry. BMC Supp; 2020
12.
Zurück zum Zitat Goldenberg RL, Nathan RO, Swanson D, Saleem S, Mirza W, Esamai F, et al. Routine antenatal ultrasound in low- and middle-income countries: first look—a cluster randomised trial. BJOG. 2018;125(12):1591–9. CrossRef Goldenberg RL, Nathan RO, Swanson D, Saleem S, Mirza W, Esamai F, et al. Routine antenatal ultrasound in low- and middle-income countries: first look—a cluster randomised trial. BJOG. 2018;125(12):1591–9. CrossRef
13.
Zurück zum Zitat Hoffman MK, Goudar SS, Kodkany BS, Goco N, Koso-Thomas M, Miodovnik M, et al. A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study. BMC Pregnancy Childbirth. 2017;17(1):135. CrossRef Hoffman MK, Goudar SS, Kodkany BS, Goco N, Koso-Thomas M, Miodovnik M, et al. A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study. BMC Pregnancy Childbirth. 2017;17(1):135. CrossRef
14.
Zurück zum Zitat Hambidge KM, Krebs NF, Westcott JE, Garces A, Goudar SS, Kodkany BS, et al. Preconception maternal nutrition: a multi-site randomized controlled trial. BMC Pregnancy Childbirth. 2014;14:111. CrossRef Hambidge KM, Krebs NF, Westcott JE, Garces A, Goudar SS, Kodkany BS, et al. Preconception maternal nutrition: a multi-site randomized controlled trial. BMC Pregnancy Childbirth. 2014;14:111. CrossRef
15.
Zurück zum Zitat Goudar SS, Carlo WA, McClure EM, Pasha O, Patel A, Esamai F, et al. The Maternal and Newborn Health Registry Study of the Global Network for Women’s and Children’s Health Research. Int J Gynaecol Obstet. 2012;118(3):190–3. CrossRef Goudar SS, Carlo WA, McClure EM, Pasha O, Patel A, Esamai F, et al. The Maternal and Newborn Health Registry Study of the Global Network for Women’s and Children’s Health Research. Int J Gynaecol Obstet. 2012;118(3):190–3. CrossRef
16.
Zurück zum Zitat Patel A, Prakash AA, Das PK, Gupta S, Pusdekar YV, Hibberd PL. Maternal anemiaandunderweight asdeterminants of pregnancy outcomes: cohort study ineastern rural Maharashtra,India. BMJ Open. 2018;8(8):e021623. CrossRef Patel A, Prakash AA, Das PK, Gupta S, Pusdekar YV, Hibberd PL. Maternal anemiaandunderweight asdeterminants of pregnancy outcomes: cohort study ineastern rural Maharashtra,India. BMJ Open. 2018;8(8):e021623. CrossRef
17.
Zurück zum Zitat Parks S, Hoffman MK, Goudar SS, Patel A, Saleem S, Ali SA, et al. Maternal anaemia and maternal, fetal, and neonatal outcomes in a prospective cohort study in India and Pakistan. BJOG. 2019;126(6):737–43. CrossRef Parks S, Hoffman MK, Goudar SS, Patel A, Saleem S, Ali SA, et al. Maternal anaemia and maternal, fetal, and neonatal outcomes in a prospective cohort study in India and Pakistan. BJOG. 2019;126(6):737–43. CrossRef
18.
Zurück zum Zitat Patel AB, Prakash AA, Raynes-Greenow C, Pusdekar YV, Hibberd PL. Description of inter-institutional referrals afteradmission for labor and delivery: a prospective population based cohort study in rural Maharashtra, India. BMC Health Serv Res. 2017;17:360. CrossRef Patel AB, Prakash AA, Raynes-Greenow C, Pusdekar YV, Hibberd PL. Description of inter-institutional referrals afteradmission for labor and delivery: a prospective population based cohort study in rural Maharashtra, India. BMC Health Serv Res. 2017;17:360. CrossRef
19.
Zurück zum Zitat Page CM, Patel A, Hibberd PL. Does smoke from biomass fuel contribute to anemia in pregnant women in Nagpur, India? A cross-sectional study. PLoS ONE. 2015;10(5):e0127890. CrossRef Page CM, Patel A, Hibberd PL. Does smoke from biomass fuel contribute to anemia in pregnant women in Nagpur, India? A cross-sectional study. PLoS ONE. 2015;10(5):e0127890. CrossRef
22.
Zurück zum Zitat Mikolajczyk RT, Zhang J, Betran AP, Souza JP, Mori R, Gülmezoglu AM, et al. A global reference for fetal-weight and birthweight percentiles. Lancet. 2011;377(9780):1855–61. CrossRef Mikolajczyk RT, Zhang J, Betran AP, Souza JP, Mori R, Gülmezoglu AM, et al. A global reference for fetal-weight and birthweight percentiles. Lancet. 2011;377(9780):1855–61. CrossRef
24.
Zurück zum Zitat de Araújo BF, Zatti H, Madi JM, Coelho MB, Olmi FB, Canabarro CT. Analysis of neonatal morbidity and mortality in late-preterm newborn infants. J Pediatr. 2012;88(3):259–66. CrossRef de Araújo BF, Zatti H, Madi JM, Coelho MB, Olmi FB, Canabarro CT. Analysis of neonatal morbidity and mortality in late-preterm newborn infants. J Pediatr. 2012;88(3):259–66. CrossRef
25.
Zurück zum Zitat Purisch SE, Gyamfi-Bannerman C. Epidemiology of preterm birth. Semin Perinatol. 2017;41(7):387–91. CrossRef Purisch SE, Gyamfi-Bannerman C. Epidemiology of preterm birth. Semin Perinatol. 2017;41(7):387–91. CrossRef
26.
Zurück zum Zitat Baig SA, Khan N, Baqai T, Fatima A, Karim SA, Aziz S. Preterm birth and its associated risk factors. A study at tertiary care hospitals of Karachi, Pakistan. J Pak Med Assoc. 2013;63(3):414–8. PubMed Baig SA, Khan N, Baqai T, Fatima A, Karim SA, Aziz S. Preterm birth and its associated risk factors. A study at tertiary care hospitals of Karachi, Pakistan. J Pak Med Assoc. 2013;63(3):414–8. PubMed
27.
Zurück zum Zitat Marchant T, Willey B, Katz J, Clarke S, Kariuki S, ter Kuile F, et al. Neonatal mortality risk associated with preterm birth in East Africa, adjusted by weight for gestational age: individual participant level meta-analysis. PLOS Med. 2012;9(8):e1001292. CrossRef Marchant T, Willey B, Katz J, Clarke S, Kariuki S, ter Kuile F, et al. Neonatal mortality risk associated with preterm birth in East Africa, adjusted by weight for gestational age: individual participant level meta-analysis. PLOS Med. 2012;9(8):e1001292. CrossRef
28.
Zurück zum Zitat Iyoke CA, Lawani LO, Ezugwu EC, Ilo KK, Ilechukwu GC, Asinobi IN. Maternal risk factors for singleton preterm births and survival at the University of Nigeria Teaching Hospital, Enugu, Nigeria. Niger J Clin Pract. 2015;18(6):744–50. CrossRef Iyoke CA, Lawani LO, Ezugwu EC, Ilo KK, Ilechukwu GC, Asinobi IN. Maternal risk factors for singleton preterm births and survival at the University of Nigeria Teaching Hospital, Enugu, Nigeria. Niger J Clin Pract. 2015;18(6):744–50. CrossRef
29.
Zurück zum Zitat Van Der Linden EL, Browne JL, Vissers KM, Antwi E, Agyepong IA, Grobbee DE, et al. Maternal body mass index and adverse pregnancy outcomes: a Ghanaian cohort study. Obesity. 2016;24(1):215–22. CrossRef Van Der Linden EL, Browne JL, Vissers KM, Antwi E, Agyepong IA, Grobbee DE, et al. Maternal body mass index and adverse pregnancy outcomes: a Ghanaian cohort study. Obesity. 2016;24(1):215–22. CrossRef
30.
Zurück zum Zitat Althabe F, Thorsten V, Klein K, McClure EM, Hibberd PL, Goldenberg RL, et al. The Antenatal Corticosteroids Trial (ACT)’s explanations for neonatal mortality—a secondary analysis. Reprod Health. 2016;13(1):62. CrossRef Althabe F, Thorsten V, Klein K, McClure EM, Hibberd PL, Goldenberg RL, et al. The Antenatal Corticosteroids Trial (ACT)’s explanations for neonatal mortality—a secondary analysis. Reprod Health. 2016;13(1):62. CrossRef
31.
Zurück zum Zitat Althabe F, Belizán JM, McClure EM, Hemingway-Foday J, Berrueta M, Mazzoni A, et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet. 2015;385(9968):629–39. CrossRef Althabe F, Belizán JM, McClure EM, Hemingway-Foday J, Berrueta M, Mazzoni A, et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet. 2015;385(9968):629–39. CrossRef
32.
Zurück zum Zitat Papageorghiou AT, Ohuma EO, Altman DG, Todros T, Cheikh Ismail L, Lambert A, et al. International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project. Lancet. 2014;384(9946):869–79. CrossRef Papageorghiou AT, Ohuma EO, Altman DG, Todros T, Cheikh Ismail L, Lambert A, et al. International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project. Lancet. 2014;384(9946):869–79. CrossRef
33.
Zurück zum Zitat Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet. 2014;384(9946):857–68. CrossRef Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet. 2014;384(9946):857–68. CrossRef
35.
Zurück zum Zitat Manasyan A, Saleem S, Koso-Thomas M, Althabe F, Pasha O, Chomba E, et al. Assessment of obstetric and neonatal health services in developing country health facilities. Am J Perinatol. 2013;30(9):787–94. CrossRef Manasyan A, Saleem S, Koso-Thomas M, Althabe F, Pasha O, Chomba E, et al. Assessment of obstetric and neonatal health services in developing country health facilities. Am J Perinatol. 2013;30(9):787–94. CrossRef
36.
Zurück zum Zitat Short VL, Geller SE, Moore JL, McClure EM, Goudar SS, Dhaded SM, et al. The relationship between body mass index in pregnancy and adverse maternal, perinatal, and neonatal outcomes in Rural India and Pakistan. Am J Perinatol. 2018;35(9):844–51. CrossRef Short VL, Geller SE, Moore JL, McClure EM, Goudar SS, Dhaded SM, et al. The relationship between body mass index in pregnancy and adverse maternal, perinatal, and neonatal outcomes in Rural India and Pakistan. Am J Perinatol. 2018;35(9):844–51. CrossRef
37.
Zurück zum Zitat Bose CL, Bauserman M, Goldenberg RL, Goudar SS, McClure EM, Pasha O, et al. The Global Network Maternal Newborn Health Registry: a multi-national, community-based registry of pregnancy outcomes. Reprod Health. 2015;12(Suppl 2):S1. CrossRef Bose CL, Bauserman M, Goldenberg RL, Goudar SS, McClure EM, Pasha O, et al. The Global Network Maternal Newborn Health Registry: a multi-national, community-based registry of pregnancy outcomes. Reprod Health. 2015;12(Suppl 2):S1. CrossRef
38.
Zurück zum Zitat Lam CM, Wong SF. Risk factors for preterm delivery in women with placenta praevia and antepartum haemorrhage: retrospective study. Hong Kong Med J. 2002;8(3):163–6. PubMed Lam CM, Wong SF. Risk factors for preterm delivery in women with placenta praevia and antepartum haemorrhage: retrospective study. Hong Kong Med J. 2002;8(3):163–6. PubMed
39.
Zurück zum Zitat Sekiguchi A, Nakai A, Kawabata I, Hayashi M, Takeshita T. Type and location of placenta previa affect preterm delivery risk related to antepartum hemorrhage. Int J Med Sci. 2013;10(12):1683–8. CrossRef Sekiguchi A, Nakai A, Kawabata I, Hayashi M, Takeshita T. Type and location of placenta previa affect preterm delivery risk related to antepartum hemorrhage. Int J Med Sci. 2013;10(12):1683–8. CrossRef
40.
Zurück zum Zitat Muchemi OM, Echoka E, Makokha A. Factors associated with low birth weight among neonates born at Olkalou District Hospital, Central Region, Kenya. Pan Afr Med J. 2015;20:108. CrossRef Muchemi OM, Echoka E, Makokha A. Factors associated with low birth weight among neonates born at Olkalou District Hospital, Central Region, Kenya. Pan Afr Med J. 2015;20:108. CrossRef
42.
Zurück zum Zitat Mondal D, Galloway TS, Bailey TC, Mathews F. Elevated risk of stillbirth in males: systematic review and meta-analysis of more than 30 million births. BMC Med. 2014;12:220. CrossRef Mondal D, Galloway TS, Bailey TC, Mathews F. Elevated risk of stillbirth in males: systematic review and meta-analysis of more than 30 million births. BMC Med. 2014;12:220. CrossRef
43.
Zurück zum Zitat Zeitlin J, Saurel-Cubizolles M-J, De Mouzon J, Rivera L, Ancel P-Y, Blondel B, et al. Fetal sex and preterm birth: are males at greater risk? Hum Reprod. 2002;17(10):2762–8. CrossRef Zeitlin J, Saurel-Cubizolles M-J, De Mouzon J, Rivera L, Ancel P-Y, Blondel B, et al. Fetal sex and preterm birth: are males at greater risk? Hum Reprod. 2002;17(10):2762–8. CrossRef
44.
Zurück zum Zitat Petersson K, Lindkvist M, Persson M, Conner P, Ahman A, Mogren I. Prenatal diagnosis in Sweden 2011 to 2013—a register-based study. BMC Pregnancy Childbirth. 2016;16:365. CrossRef Petersson K, Lindkvist M, Persson M, Conner P, Ahman A, Mogren I. Prenatal diagnosis in Sweden 2011 to 2013—a register-based study. BMC Pregnancy Childbirth. 2016;16:365. CrossRef
45.
Zurück zum Zitat Committee on Obstetric Practice, The American Institute of Ultrasound in Medicine, The Society for Maternal- Fetal Medicine. Committee Opinion No 700: Methods for estimating the due date. Obstet Gynecol. 2017;129:e150. CrossRef Committee on Obstetric Practice, The American Institute of Ultrasound in Medicine, The Society for Maternal- Fetal Medicine. Committee Opinion No 700: Methods for estimating the due date. Obstet Gynecol. 2017;129:e150. CrossRef
46.
Zurück zum Zitat Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco MC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–22. CrossRef Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco MC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–22. CrossRef
47.
Zurück zum Zitat Kallen B, Finnstrom O, Nygren KG, Olausson PO. Maternal and fetal factors which affect fetometry: Use of in-vitro fertilization and birth register data. Eur J Obstet Gynecol Reprod Biol. 2013;170:372–6. CrossRef Kallen B, Finnstrom O, Nygren KG, Olausson PO. Maternal and fetal factors which affect fetometry: Use of in-vitro fertilization and birth register data. Eur J Obstet Gynecol Reprod Biol. 2013;170:372–6. CrossRef
48.
Zurück zum Zitat Harland KK, Saftlas AF, Wallis AB, Yankowitz J, Triche EW, Zimmerman MB. Correction of systematic bias in ultrasound dating in studies of small-for-gestational-age birth: an example from the Iowa health in pregnancy study. Am J Epidemiol. 2012;176:443–55. CrossRef Harland KK, Saftlas AF, Wallis AB, Yankowitz J, Triche EW, Zimmerman MB. Correction of systematic bias in ultrasound dating in studies of small-for-gestational-age birth: an example from the Iowa health in pregnancy study. Am J Epidemiol. 2012;176:443–55. CrossRef
Metadaten
Titel
Rates and risk factors for preterm birth and low birthweight in the global network sites in six low- and low middle-income countries
verfasst von
Yamini V. Pusdekar
Archana B. Patel
Kunal G. Kurhe
Savita R. Bhargav
Vanessa Thorsten
Ana Garces
Robert L. Goldenberg
Shivaprasad S. Goudar
Sarah Saleem
Fabian Esamai
Elwyn Chomba
Melissa Bauserman
Carl L. Bose
Edward A. Liechty
Nancy F. Krebs
Richard J. Derman
Waldemar A. Carlo
Marion Koso-Thomas
Tracy L. Nolen
Elizabeth M. McClure
Patricia L. Hibberd
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
Reproductive Health / Ausgabe Sonderheft 3/2020
Elektronische ISSN: 1742-4755
DOI
https://doi.org/10.1186/s12978-020-01029-z

Weitere Artikel der Sonderheft 3/2020

Reproductive Health 3/2020 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.